Skip to content

Determination of Parathyroid Function by Fluorescence With Indocyanine Green (ICG) After Total Thyroidectomy

Determination of Parathyroid Function by Fluorescence With Indocyanine Green (ICG) After Total Thyroidectomy

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04012476
Enrollment
40
Registered
2019-07-09
Start date
2016-11-30
Completion date
2020-10-31
Last updated
2019-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypocalcemia, Hypoparathyroidism Postprocedural, Total Thyroidectomy

Keywords

Hypocalcemia post-thyroidectomy, Indocyanine green, Fluorescence guided surgery, Parathyroid fluorescence

Brief summary

The intensity of parathyroid fluorescence that occurs after intravenous injection of indocyanine green during the performance of a total thyroidectomy correlates with postoperative parathyroid function and could be used as a diagnostic marker of postoperative hypoparathyroidism and hypocalcemia.

Detailed description

The main objective of the study is to compare the intensity of parathyroid fluorescence among patients who present post-thyroidectomy hypocalcemia with that of patients who do not have it. Therefore, the following points will be studied: * To study the correlation between parathyroid vascularization (intraoperative fluorescence intensity) and postoperative glandular function (serum calcium and parathormone levels). * To compare the surgeon's subjective assessment of parathyroid fluorescence in the groups of patients with and without postoperative hypocalcemia. * To compare the objective assessment of parathyroid fluorescence, by using specific computer software developed ad hoc, in the groups of patients with and without postoperative hypocalcemia.

Interventions

DRUGIndocyanine Green

Administration of 5 mg of intravenous indocyanine green after total thyroidectomy for measurement of parathyroid fluorescence under infrared light

Sponsors

Universitat de les Illes Balears
CollaboratorOTHER
Hospital Son Espases
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Single group: patients undergoing total thyroidectomy with intraoperative infusion of intravenous indocyanine green A prospective unicentric and open clinical trial in which the fluorescence intensity of the parathyroid glands after indocyanine administration will be compared between two groups of patients: those with post-thyroidectomy hypocalcemia and patients who do not present it.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who are going to undergo total thyroidectomy, with or without cervical lymph node dissection. * Visualization of 2 or more parathyroid glands during the surgical act. * Normal renal and hepatic functions. * Absence of a history of hypersensitivity reactions to iodine or indocyanine green. * Able to understand the nature and protocol of the study and its procedures * Willingness to participate with the subsequent signing of informed consent.

Exclusion criteria

* Age \<18 years * Hepatic or renal insufficiency * Hypersensitivity to iodine or to indocyanine green. * Pregnancy or lactation * Inability to understand the nature and procedures of the study. * Patients with known preoperative hyperparathyroidism.

Design outcomes

Primary

MeasureTime frameDescription
CalcemiaDay 1 after surgerySerum calcium level at 24 hours postoperatively
Subjective parathyroid fluorescenceIntraoperativelyFluorescence intensity of the parathyroid glands after administration of indocyanine green (ICG), measured on a subjective analogue scale (0: no fluorescence, 1: hypofluorescence or heterogeneous fluorescence, 2: homogeneous hyperfluorescence).
Objective parathyroid fluorescenceIntraoperativelyFluorescence intensity of the parathyroid glands after administration of indocyanine green (ICG), measured by specific computer software developed ad hoc.

Secondary

MeasureTime frameDescription
Surgery dateBaselineDay when surgery takes place
Preoperative diagnosisBaselineThyroid pathology indicating total thyroidectomy (thyroid carcinoma, atypical of uncertain significance, goiter or lymphocytic thyroiditis)
Vitamin DPreoperative blood testPreoperative vitamin D level
PTH preopImmediately before surgeryPreoperative PTH level
PTH 10 min10 minutes post-thyroidectomyPTH levels 10 minutes post-thyroidectomy
SurgeryInmediately after surgeryScope of surgery: total thyroidectomy (TT), TT with central neck dissection, or TT with functional lateral neck dissection
TimeInmediately after surgeryDuration of surgery
Parathyroid glandsDuring surgeryNumber of parathyroid glands located during surgery,
AgeBaselinePatient's age
Pathologic resultduring the first month after surgeryOutcome of thyroid pathology (papillary carcinoma, nodular hyperplasia or lymphocytic thyroiditis)
Thyroid weightduring the first month after surgeryThyroid weight
PG in pieceduring the first month after surgeryPresence of parathyroid glands in the surgical piece and number
StayDuring the first month after surgeryNumber of days of postoperative hospital stay until the day of hospital discharge, measured as full days of 24 hours
DrainInmediately after surgeryPresence and number of surgical drainages
PTH day 1Day 1 after surgeryPTH levels in the postoperative follow-up,
ComplicationsDuring the first month after surgeryEmergence of postoperative complications.
Parathyroid gland locationDuring surgeryLocation of the parathyroid glands (superior right, inf-right, sup-left, inf-left).
SexBaselinePatient's gender
Body mass indexBaselinePatient's BMI

Countries

Spain

Contacts

Primary ContactJaime Bonnín Pascual, MD
jaime.bonnin@ssib.es871205959

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026